Ku Sheng-Yu相关文献与解析，生知库 | 链接生命科学的每一步

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

晚期前列腺癌表型亚型的个体内部表观遗传异质性

Mizuno Kei, Ku Sheng-Yu, Venkadakrishnan Varadha Balaji, Bakht Martin K, Sigouros Michael, Chan Joanna, Trigos Anna, Driskill Jordan H, Manohar Jyothi, King Abigail, Presser Adam G, Kim Min Jin, Tewari Alok K, Long Henry W, Quigley David, Choueiri Toni K, Balk Steven, Hill Sarah, Mosquera Juan Miguel, Einstein David, Sandhu Shahneen, Taplin Mary-Ellen, Beltran Himisha

表观遗传

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

MUC1-C 在耐药性前列腺癌中的依赖性揭示了抗体药物偶联疗法的靶点

期刊:JCI Insight

影响因子:6.1

doi:10.1172/jci.insight.190924

Shigeta Keisuke, Daimon Tatsuaki, Hongo Hiroshi, Ku Sheng-Yu, Ozawa Hiroki, Haratake Naoki, Fushimi Atsushi, Nakashoji Ayako, Bhattacharya Atrayee, Takamori Shinkichi, Kono Michihisa, Rokugo Masahiro, Baba Yuto, Kosaka Takeo, Oya Mototsugu, Jacobi Justine, Long Mark D, Beltran Himisha, Kufe Donald

Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression

更正：PTEN调控的PI3K-p110和AKT亚型可塑性控制转移性前列腺癌的进展

期刊:Oncogene

影响因子:7.3

doi:10.1038/s41388-023-02920-2

Miller, Karina A; Degan, Seamus; Wang, Yanqing; Cohen, Joseph; Ku, Sheng Yu; Goodrich, David W; Gelman, Irwin H

Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.

针对 RB1 缺陷型和神经内分泌型前列腺癌中的 DNA 甲基化和 B7-H3

期刊:Science Translational Medicine

影响因子:14.6

doi:10.1126/scitranslmed.adf6732

Yamada Yasutaka, Venkadakrishnan Varadha Balaji, Mizuno Kei, Bakht Martin, Ku Sheng-Yu, Garcia Maria Mica, Beltran Himisha

Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

作者更正：通过单细胞拷贝数分析研究神经内分泌前列腺癌中循环肿瘤细胞的异质性

期刊:npj Precision Oncology

影响因子:8

doi:10.1038/s41698-021-00227-7

Conteduca, Vincenza; Ku, Sheng-Yu; Fernandez, Luisa; Dago-Rodriquez, Angel; Lee, Jerry; Jendrisak, Adam; Slade, Megan; Gilbertson, Cole; Manohar, Jyothi; Sigouros, Michael; Wang, Yipeng; Dittamore, Ryan; Wenstrup, Rick; Mosquera, Juan Miguel; Schonhoft, Joseph D; Beltran, Himisha

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

通过单细胞拷贝数分析研究神经内分泌前列腺癌中循环肿瘤细胞的异质性

期刊:npj Precision Oncology

影响因子:8

doi:10.1038/s41698-021-00211-1

Epigenetics in prostate cancer: clinical implications

前列腺癌的表观遗传学：临床意义

期刊:Translational Andrology and Urology

影响因子:1.7

doi:10.21037/tau-20-1339

Conteduca, Vincenza; Hess, Judy; Yamada, Yasutaka; Ku, Sheng-Yu; Beltran, Himisha

Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma

血管生成素-TIE2和MET的双重抑制可改变肾细胞癌转移模型中的肿瘤微环境并延长生存期

期刊:Molecular Cancer Therapeutics

影响因子:5.5

doi:10.1158/1535-7163.MCT-18-1202

Elbanna, May; Orillion, Ashley R; Damayanti, Nur P; Adelaiye-Ogala, Remi; Shen, Li; Miles, Kiersten Marie; Chintala, Sreenivasulu; Ciamporcero, Eric; Ramakrishnan, Swathi; Ku, Sheng-Yu; Rex, Karen; Caenepeel, Sean; Coxon, Angela; Pili, Roberto

SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy

晚期前列腺癌中SLFN11的表达及其对铂类化疗的反应

期刊:Molecular Cancer Therapeutics

影响因子:5.5

doi:10.1158/1535-7163.MCT-19-0926

Conteduca, Vincenza; Ku, Sheng-Yu; Puca, Loredana; Slade, Megan; Fernandez, Luisa; Hess, Judy; Bareja, Rohan; Vlachostergios, Panagiotis J; Sigouros, Michael; Mosquera, Juan Miguel; Sboner, Andrea; Nanus, David M; Elemento, Olivier; Dittamore, Ryan; Tagawa, Scott T; Beltran, Himisha

Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer

DLL3靶向T细胞衔接剂MK-6070在神经内分泌前列腺癌中的临床前活性

Intraindividual epigenetic heterogeneity underlying phenotypic subtypes of advanced prostate cancer.

晚期前列腺癌表型亚型的个体内部表观遗传异质性

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

MUC1-C 在耐药性前列腺癌中的依赖性揭示了抗体药物偶联疗法的靶点

Correction: PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression

更正：PTEN调控的PI3K-p110和AKT亚型可塑性控制转移性前列腺癌的进展

Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.

针对 RB1 缺陷型和神经内分泌型前列腺癌中的 DNA 甲基化和 B7-H3

Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

作者更正：通过单细胞拷贝数分析研究神经内分泌前列腺癌中循环肿瘤细胞的异质性

Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis

通过单细胞拷贝数分析研究神经内分泌前列腺癌中循环肿瘤细胞的异质性

Epigenetics in prostate cancer: clinical implications

前列腺癌的表观遗传学：临床意义

Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma

血管生成素-TIE2和MET的双重抑制可改变肾细胞癌转移模型中的肿瘤微环境并延长生存期

SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy

晚期前列腺癌中SLFN11的表达及其对铂类化疗的反应